Simultaneous Detection of Collagen I Alpha II and Cytokeratin 19 mRNA by Multiplex qPCR in Liquid Biopsy in Diagnosis of Patients with Resectable Solid Tumors
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25179567 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Lara Sofía Estévez Pérez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Biomedical Research Institute A Coruña (INIBIC), University Hospital Complex A Coruña, 15006 A Coruña, Spain. Hauptthemen laut MEDLINE: Keratin-19, Biomarkers, Tumor, Collagen Type I, RNA, Messenger. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Plan de Innovación Sanitaria Codigo100, Servizo Galego de Saúde, Xunta de Galicia, Fundación Profesor Nova Santos.
Abstract (Originalsprache)
The early detection of tumors is one of the key factors in increasing overall survival in cancer patients. A wide range of cancers still do not have a system of early diagnosis; therefore, the development of new non-invasive tools in this line is essential. Accordingly, the objective of our work was to develop a non-invasive screening method for the early detection of various carcinomas in plasma using a panel that combines two markers using RT-qPCR. A retrospective case-control study was conducted to develop a cancer screening test based on the detection of stromal and epithelial biomarkers (COL1A2 and KRT19) in plasma. The expression of biomarkers was evaluated using multiplex quantitative PCR applied to 47 cases with non-metastatic tumors and 13 control participants. For both biomarkers, a cut-off value was stablished using Youden’s J index through ROC curve analysis and areas under the curve (AUC) were calculated. The plasma mRNA expression level of both biomarkers was significantly higher in diseased versus healthy patients. Moreover, ROC curve analysis showed an AUC value of 0.897 for the combined model. This model also resulted in a cutoff value of 0.664, as well as a sensitivity of 83% and a specificity of 84.6%. These results suggest that the plasma expression levels of COL1A2 and KRT19 could a have potential role in detecting various types of cancer at the early stages. The combined analysis of both stromal and epithelial biomarkers would provide a non-invasive screening method that would allow us to differentiate patients with an active neoplastic process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology Department, Biomedical Research Institute A Coruña (INIBIC), University Hospital Complex A Coruña, 15006 A Coruña, Spain.
- Santiago de Compostela Health Research Institute (IDIS), University Hospital Complex Santiago de Compostela, 15706 Santiago de Compostela, Spain.
- Oncomatryx Biopharma, 48160 Derio, Spain.
ORCID-Profile: Begoña O Alén
Förderung
- Plan de Innovación Sanitaria Codigo100, Servizo Galego de Saúde, Xunta de Galicia
- Fundación Profesor Nova Santos
Zitieren
APA
Estévez Pérez, L. S., Alén, B. O., Otero Alén, M., Hormaetxe, S. D., Simón, L., & Concha, Á. (2024). Simultaneous Detection of Collagen I Alpha II and Cytokeratin 19 mRNA by Multiplex qPCR in Liquid Biopsy in Diagnosis of Patients with Resectable Solid Tumors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179567
Vancouver
Estévez Pérez LS, Alén BO, Otero Alén M, Hormaetxe SD, Simón L, Concha Á. Simultaneous Detection of Collagen I Alpha II and Cytokeratin 19 mRNA by Multiplex qPCR in Liquid Biopsy in Diagnosis of Patients with Resectable Solid Tumors. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179567
BibTeX
@article{EstvezPrez2024,
author = {Estévez Pérez, Lara Sofía and Alén, Begoña O and Otero Alén, María and Hormaetxe, Saioa Domínguez and Simón, Laureano and Concha, Ángel},
title = {Simultaneous Detection of Collagen I Alpha II and Cytokeratin 19 mRNA by Multiplex qPCR in Liquid Biopsy in Diagnosis of Patients with Resectable Solid Tumors},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25179567}
}
EUVIMED